Clinical trial
Critical Limb Ischemia Treatment by Local Intra-Muscular Injection of Autologous Mononuclear Cells
NCT00533104 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Critical Limb Ischemia Treatment by Local Intra-Muscular Injection of Autologous Mononuclear Cells
- Lead sponsor
- CHU de Reims
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- February 28, 2009
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.